doi: 10.1186/1755-8794-7-29, 26
Discovery of human zinc deficiency: its impact on human health and disease
Martin B, Shin Y-K, White CM, Ji S, Kim W, Carlson OD, et al
Regulatory hurdles: Approval for novel indications (Alzheimers, neurodegenerative diseases) requires very high bar: long follow-ups, clinically meaningful endpoints, safety
The phase 2 signal that put retatrutide on the map The pivotal early evidence is the phase 2 trial published in the New England Journal of Medicine in 2023, which randomized 338 adults with obesity to escalating retatrutide doses or placebo over 48 weeks
With L-Carnitine, consistency plays a much larger role than obsessing over exact timing